Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells

Diabetes, Obesity and Metabolism

Volumn 16, Issue 7, 2014, Pages 602-612

  Bhattacharya, S ^a   Oksbjerg, N ^a   Young, J F ^a   Jeppesen, P B ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Gene expression; Glucotoxicity; Hyperglycaemia; INS 1E cells; Insulin secretion; Phenolic compounds; Type 2 diabetes; cells

Indexed keywords

ACETYL COA CARBOXYLASE 1; ACETYL COENZYME A CARBOXYLASE; AKT1 PROTEIN; BETA CELL LYMPHOMA 2 PROTEIN; CAFFEIC ACID; CASPASE 3; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; INSULIN; INSULIN 1; INSULIN RECEPTOR SUBSTRATE 1; NARINGENIN; NEUROGENIC DIFFERENTIATION PROTEIN 1; PROTEIN; PROTEIN BAX; PROTEIN KINASE B BETA; QUERCETIN; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG; CAFFEIC ACID DERIVATIVE; FLAVANONE DERIVATIVE; MESSENGER RNA; PLANT MEDICINAL PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE SENSITIVITY; GLUCOTOXICITY; GUINEA PIG; INS 1 CELL LINE; INSULIN RELEASE; LONG TERM EXPOSURE; NONHUMAN; PANCREAS ISLET BETA CELL; PHYSICAL SENSITIVITY; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM; PHYTOTHERAPY; RAT; SECRETION (PROCESS); SECRETORY PATHWAY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CAFFEIC ACIDS; CELL LINE; CELL SURVIVAL; FLAVANONES; GENE EXPRESSION; GLUCOKINASE; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; PHYTOTHERAPY; PLANT PREPARATIONS; QUERCETIN; RATS; RNA, MESSENGER; SECRETORY PATHWAY; SIGNAL TRANSDUCTION;

EID: 84903182474     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12236     Document Type: Article

References (47)

1. Ambady R, Snehalatha C, Shetty AS, Nanditha A. Primary prevention of Type 2 diabetes in South Asians challenges and the way forward. Diabet Med 2013; 30: 26-34.
2. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: 787-794.
3. Bensellam M, Laybutt DR, Jonas JC. The molecular mechanisms of pancreatic beta-cell glucotoxicity: recent findings and future research directions. Mol Cell Endocrinol 2012; 364: 1-27.
4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
5. Efrat S. Beta-cell expansion for therapeutic compensation of insulin resistance in type 2 diabetes. Int J Exp Diabesity Res 2003; 4: 1-5.
6. Robertson RP, Harmon J, Tran POT, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53: S119-124.
7. Kaiser N, Leibowitz G, Nesher R. Glucotoxicity and beta-cell failure in type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2003; 16: 5-22.
8. Cheng AYY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. Can Med Assoc J 2005; 172: 213-226.
9. Noh RM, Graveling AJ, Frier BM. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review. Expert Opin Pharmacother 2011; 12: 2161-2175.
10. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine 1995; 2: 137-189.
11. Lee ISL, Boyce MC, Breadmore MC. A rapid quantitative determination of phenolic acids in Brassica oleracea by capillary zone electrophoresis. Food Chem 2011; 127: 797-801.
12. Felgines C, Texier O, Morand C et al. Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1148-1154.
13. Jan AT, Kamli MR, Murtaza I, Singh JB, Ali A, Haq QMR. Dietary flavonoid quercetin and associated health benefits-an overview. Food Rev Int 2010; 26: 302-317.
14. Lin CY, Ni CC, Yin MC, Lii CK. Flavonoids protect pancreatic beta-cells from cytokines mediated apoptosis through the activation of PI3-kinase pathway. Cytokine 2012; 59: 65-71.
15. He X, Liu RH. Phytochemicals of apple peels: isolation, structure elucidation, and their antiproliferative and antioxidant activities. J Agric Food Chem 2008; 56: 9905-9910.
16. Asfari M, Janjic D, Meda P, Li GD, Halban PA, Wollheim CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell-lines. Endocrinology 1992; 130: 167-178.
17. + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000; 49: 424-430.
18. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 2004; 145: 667-678.
19. Valentova K, Truong N, Moncion A, De Waziers I, Ulrichova J. Induction of glucokinase mRNA by dietary phenolic compounds in rat liver cells in vitro. J Agric Food Chem 2007; 55: 7726-7731.
20. Fyfe MCT, White JR, Taylor A et al. Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions. Diabetologia 2007; 50: 1277-1287.
21. Tsuda S, Egawa T, Ma X, Oshima R, Kurogi E, Hayashi T. Coffee polyphenol caffeic acid but not chlorogenic acid increases 5' AMP-activated protein kinase and insulin-independent glucose transport in rat skeletal muscle. J Nutr Biochem 2012; 23: 1403-1409.
22. El-Mahdy MA, Zhu Q, Wang QE et al. Naringenin protects HaCaT human keratinocytes against UVB-induced apoptosis and enhances the removal of cyclobulane pyrimidine dimers from the genome. Photochem Photobiol 2008; 84: 307-316.
23. Sarkar A, Angeline MS, Anand K, Ambasta RK, Kumar P. Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit neuroprotective response in the murine model. Brain Res 2012; 1481: 59-70.
24. Doliba NM, Fenner D, Zelent B, Bass J, Sarabu R, Matschinsky FM. Repair of diverse diabetic defects of beta-cells in man and mouse by pharmacological glucokinase activation. Diabetes Obes Metab 2012; 14: 109-119.
25. Nakamura A, Terauchi Y, Ohyama S et al. Impact of small-molecule glucokinase activator on glucose metabolism and beta-cell mass. Endocrinology 2009; 150: 1147-1154.
26. Elghazi L, Rachdi L, Weiss AJ, Cras-Meneur C, Bernal-Mizrachi E. Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab 2007; 9: 147-157.
27. Garofalo RS, Orena SJ, Rafidi K et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 2003; 112: 197-208.
28. Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005; 146: 1025-1034.
29. Tong L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell Mol Life Sci 2005; 62: 1784-1803.
30. Bensellam M, Van Lommel L, Overbergh L, Schuit FC, Jonas JC. Cluster analysis of rat pancreatic islet gene mRNA levels after culture in low-, intermediate- and high-glucose concentrations. Diabetologia 2009; 52: 463-476.
31. Chen J, Jeppesen PB, Nordentoft I, Hermansen K. Stevioside improves pancreatic beta-cell function during glucotoxicity via regulation of acetyl-CoA carboxylase. Am J Physiol Endocrinol Metab 2007; 292: E1906-1916.
32. Lin P, Chen L, Li D et al. Adiponectin reduces glucotoxicity-induced apoptosis of INS-1 rat insulin-secreting cells on a microfluidic chip. Tohoku J Exp Med 2009; 217: 59-65.
33. Gregersen S, Hermansen K, Yanaihara N, Ahren B. Galanin fragments and analogs - effects on glucose-stimulated insulin-secretion from isolated rat islets. Pancreas 1991; 6: 216-220.
34. +-channel activity. Metabolism 2000; 49: 208-214.
35. Meloni AR, DeYoung MB, Lowe C, Parkes DG. GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence. Diabetes Obes Metab 2013; 15: 15-27.
36. Efrat S. Making sense of glucose sensing. Nat Genet 1997; 17: 249-250.
37. Vogler M. BCL2A1: the underdog in the BCL2 family. Cell Death Differ 2012; 19: 67-74.
38. Soti C, Nagy E, Giricz Z, Vigh L, Csermely P, Ferdinandy P. Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 2005; 146: 769-780.
39. Zhang SY, Kim KH. Essential role of acetyl-CoA carboxylase in the glucose-induced insulin secretion in a pancreatic beta-cell line. Cell Signal 1998; 10: 35-42.
40. Cnop M, Ladriere L, Igoillo-Esteve M, Moura RF, Cunha DA. Causes and cures for endoplasmic reticulum stress in lipotoxic beta-cell dysfunction. Diabetes Obes Metab 2010; 12: 76-82.
41. Zygmunt K, Faubert B, MacNeil J, Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. Biochem Biophys Res Commun 2010; 398: 178-183.
42. Bai NS, He K, Roller M et al. Active compounds from Lagerstroemia speciosa, insulin-like glucose uptake-stimulatory/inhibitory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Agric Food Chem 2008; 56: 11668-11674.
43. Huang DW, Shen SC, Wu JSB. Effects of caffeic acid and cinnamic acid on glucose uptake in insulin-resistant mouse hepatocytes. J Agric Food Chem 2009; 57: 7687-7692.
44. Chuang CC, Martinez K, Xie GX et al. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-alpha-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr 2010; 92: 1511-1521.
45. Youl E, Bardy G, Magous R et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol 2010; 161: 799-814.
46. Bardy G, Virsolvy A, Quignard JF et al. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol 2013; 169: 1102-1113.
47. 2+-dependent exocytosis and release of arachidonic acid in cultured mast cells (RBL-2H3) by quercetin. Int J Immunopharmacol 2000; 22: 747-754.